 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| . |  |
. |
Harmless Virus May Help Fight Bird Flu
Purdue University researchers say a harmless virus used as a delivery vehicle for vaccines might help prevent a pandemic of bird flu. Purdue molecular virologist Suresh Mittal and colleagues are investigating a new way to provide immunity against avian influenza viruses, or bird flu. The most lethal strain, H5N1, has a 50-percent fatality rate in humans. Under a $1.6 million grant from the National Institute of Allergy and Infectious Diseases, the Purdue researchers are focusing on using adenovirus as a transmitting agent for a vaccine to fight such highly virulent strains of avian influenza. A major advantage to using adenovirus is that it can be mass produced much more quickly than with current methods. "The ultimate goal of our research is to develop an effective avian influenza virus vaccine that will provide long-lasting and broad immunity against multiple strains of this virus," Mittal said.
Less virulent bird flu may infect humans Crossing the species barrier is an important step in the development of a flu virus with pandemic potential, the scientists noted. Previous studies have focused on the ability of highly pathogenic bird flu strains, such as H5N1 in Asia, spreading to humans. The new study, however, shows less pathogenic strains are also capable of jumping to humans. Isabella Donatelli of Istituto Superiore di Sanita in Rome and colleagues studied outbreaks in northern Italy occurring among poultry between 1999 and 2003. The investigators said their work provides the first serologic evidence of transmission of low pathogenic strains of avian influenza virus to humans during an outbreak in domestic poultry. The researchers emphasize their study probably underestimates the real infection rate because blood samples were considered positive only if they repeatedly produced unequivocal positive results using several different serologic techniques. Details of the study appear in the Oct. 1 issue of The Journal of Infectious Diseases, now available online. All rights reserved. � 2005 United Press International. Sections of the information displayed on this page (dispatches, photographs, logos) are protected by intellectual property rights owned by United Press International. As a consequence, you may not copy, reproduce, modify, transmit, publish, display or in any way commercially exploit any of the content of this section without the prior written consent of United Press International. Related Links TerraDaily Search TerraDaily Subscribe To TerraDaily Express 
Drug Resistant Bird Flu In Southeast Asia
Memphis (UPI) Sep 12, 2005Resistance to the anti-viral drug amantadine is spreading more rapidly among avian influenza viruses of H5N1 subtype in Southeast Asia than in North America.
|
|
| |||||||||
| The content herein, unless otherwise known to be public domain, are Copyright 1995-2016 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement All images and articles appearing on Space Media Network have been edited or digitally altered in some way. Any requests to remove copyright material will be acted upon in a timely and appropriate manner. Any attempt to extort money from Space Media Network will be ignored and reported to Australian Law Enforcement Agencies as a potential case of financial fraud involving the use of a telephonic carriage device or postal service. |
